Drug intelligence / Profile preview

lidocaine + epinephrine + fentanyl

Development stage
Phase 2
Lead developer
AstraZeneca
Modality
Small Molecules, Peptides
Administration
Epidural, Intrathecal
01

Overview

This is a combination of three drugs—lidocaine, epinephrine, and fentanyl—used primarily in regional anesthesia (such as epidural or spinal anesthesia) for surgical procedures including cesarean section. - **Lidocaine** is an amide-type local anesthetic that works by blocking sodium channels (specifically the sodium channel protein type 1 subunit alpha), thereby inhibiting nerve impulse conduction and producing loss of sensation in the targeted area[4]. - **Epinephrine** acts as a vasoconstrictor by stimulating adrenergic receptors (alpha-adrenergic receptor agonist), which reduces systemic absorption of lidocaine, prolongs its effect, and decreases bleeding at the site[1][3][6]. - **Fentanyl** is a potent synthetic opioid analgesic that acts primarily on mu-opioid receptors to provide additional pain relief during procedures[7][8]. The addition of fentanyl to lidocaine/epinephrine solutions has been shown to increase the duration and quality of postoperative analgesia without significantly increasing adverse effects. This combination is commonly used in obstetric anesthesia for cesarean sections due to its efficacy in providing rapid onset sensory block with prolonged pain control[1][3][5][6].

Other names
lidocaine with epinephrine and fentanyllidocaine-epinephrine-fentanyl combination
02

Targets

ADRA1 (Alpha-1 adrenergic receptor family)MOR (Mu opioid receptor)SCN1A (Voltage-gated sodium channel protein type 1 subunit alpha)

Beyond the preview

Go deeper on lidocaine + epinephrine + fentanyl.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on lidocaine + epinephrine + fentanyl.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call